FDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.
5 reports, 1 independent
Updated Oct 7
Gone quiet
- Reports
- 5
- Developments
- 3
- Repetition
- 40%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Clearmind Medicine Inc. held clinical trials at Yale and Johns Hopkins and submitted data to the FDA.1 source
Clearmind Medicine Inc. is undergoing FDA-overseen trials in the US and Israel.1 source
Clearmind Medicine Inc. achieves Nasdaq listing, FDA oversight, and clinical trial partnerships.1 source
Keep exploring
The entities involved
Related events
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- EyePoint Pharmaceuticals developed its LUCIA trial program in alignment with the FDA, with enrollment noted in Lugano.
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- FDA approved a medical device from Abbott and supported a PARADIGM study based on data from the Cleveland Clinic.
Coverage
Newest first; wire copies grouped- manilatimes.net
- manilatimes.net
- manilatimes.netClearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
- manilatimes.net
- manilatimes.net